Search

3i Group PLC

Закрыт

СекторИндексы

3,341 -0.92

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

3232

Макс.

3388

Ключевые показатели

By Trading Economics

Доход

3B

Продажи

1.6B

P/E

Средняя по отрасли

8.273

18.062

Прибыль на акцию

3.09

Дивидендная доходность

1.74

Рентабельность продаж

188.169

Сотрудники

223

EBITDA

3B

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+40.08% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

1.74%

8.03%

Дата следующей выплаты дивидендов

9 янв. 2026 г.

Следующая эксдивидендная дата

27 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.7B

44B

Предыдущая цена открытия

3341.92

Предыдущая цена закрытия

3341

3i Group PLC График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 нояб. 2025 г., 10:02 UTC

Отчет
Главные движущие силы рынка

3i Group Shares Tumble After Cautious Outlook

13 нояб. 2025 г., 07:29 UTC

Отчет

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 нояб. 2025 г., 07:29 UTC

Отчет

3i Group PLC Declares Dividend of 36.5p

13 нояб. 2025 г., 07:28 UTC

Отчет

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 нояб. 2025 г., 07:28 UTC

Отчет

3i Group Ended Period With Liquidity of GBP1.64B

13 нояб. 2025 г., 07:26 UTC

Отчет

3i Group: Several of Other Large Portfolio Companies Are Showing Good Momentum

13 нояб. 2025 г., 07:25 UTC

Отчет

3i Group: Action Continued to Trade Strongly

13 нояб. 2025 г., 07:25 UTC

Отчет

3i Group Private Equity Business Delivered a Gross Investment Return of GBP3.23B

13 нояб. 2025 г., 07:25 UTC

Отчет

3i Group Total Return GBP3.29B, or 13% on Opening Shareholders' Funds

13 нояб. 2025 г., 07:12 UTC

Отчет

3i Group: Action Generated Net Sales of EUR11.23B in Nine Reporting Periods Ending Sep. 28

13 нояб. 2025 г., 07:07 UTC

Отчет

3i Group Private Equity Business Gross Investment Return GBP3.23B

13 нояб. 2025 г., 07:07 UTC

Отчет

3i Group Had Liquidity of GBP1.64B at Sep. 30

13 нояб. 2025 г., 07:07 UTC

Отчет

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 нояб. 2025 г., 07:05 UTC

Отчет

3i Group Raises Dividend to 36.5p Vs 30.5p

13 нояб. 2025 г., 07:03 UTC

Отчет

3i Group: Transaction Market and Wider Environment Likely to Remain Challenging Into Fiscal 2H

13 нояб. 2025 г., 07:03 UTC

Отчет

3i Group: Remain Cautious in Deployment of Capital Into New Investment, Will Continue to Allocate Selectively

13 нояб. 2025 г., 07:02 UTC

Отчет

3i Group 1H NAV/Shr 2,857p

13 нояб. 2025 г., 07:02 UTC

Отчет

3i Group Total Return GBP3.29B

13 нояб. 2025 г., 07:00 UTC

Отчет

3i 1H EPS GBP3.398

13 нояб. 2025 г., 07:00 UTC

Отчет

3i 1H NAV/Shr GBP28.57

2 сент. 2025 г., 11:16 UTC

Обсуждения рынка

3i Group Seems to Value Investments Conservatively -- Market Talk

2 сент. 2025 г., 06:40 UTC

Приобретения, слияния, поглощения

3i Group: Price is 30% Premium to MAIT's March 31 Valuation

2 сент. 2025 г., 06:39 UTC

Приобретения, слияния, поглощения

3i Group Selling MAIT for GBP143M

2 сент. 2025 г., 06:38 UTC

Приобретения, слияния, поглощения

3i Group: DBAG is a Private Equity Fund Advised by Deutsche Beteiligungs

2 сент. 2025 г., 06:38 UTC

Приобретения, слияния, поглощения

3i Group: MAIT is IT Services Provider for Mid-Market Customers in DACH Region

2 сент. 2025 г., 06:38 UTC

Приобретения, слияния, поглощения

3i Group to Sell MAIT to DBAG

24 июл. 2025 г., 06:09 UTC

Отчет

3i Group: Focus on Actively Managing Portfolio, Remain Cautious on Pricing for New Investment

24 июл. 2025 г., 06:09 UTC

Отчет

3i Group: Resilient Performance from Majority of Remaining Private Equity Portfolio

24 июл. 2025 г., 06:09 UTC

Отчет

3i Group 1Q Foreign Exchange Translation Gain GBP392M

24 июл. 2025 г., 06:04 UTC

Отчет

3i Group YTD Operating EBITDA GBP980M

3i Group PLC Прогноз

Целевая цена

By TipRanks

40.08% рост

Прогноз на 12 месяцев

Средняя 4,706.67 GBX  40.08%

Максимум 5,200 GBX

Минимум 4,100 GBX

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для 3i Group PLC на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

7 ratings

5

Покупка

2

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat